Interleukin (IL)-35 Suppresses IL-6 and IL-8 Production in IL-17A-Stimulated Human Periodontal Ligament Cells
- 113 Downloads
Interleukin (IL)-35 is a novel anti-inflammatory cytokine that is produced by regulatory T cells. IL-35 is reported to suppress IL-17A-producing helper T (Th17) cell activation. IL-17A is related to progression of periodontitis. Furthermore, IL-35 and IL-17A are detected in human gingival crevicular fluid. However, the effect of IL-35 and interaction between IL-35 and IL-17A on pro-inflammatory cytokine production in human periodontal resident cells are still unclear. The aim of this study was to clarify the effect of IL-35 on IL-6 and IL-8 production in human periodontal ligament cells (HPDLCs) stimulated with IL-17A. IL-35 inhibited IL-6 and IL-8 production in IL-17A-stimulated HPDLCs. Moreover, western blot analysis showed that IL-35 suppressed extracellular signal-regulated kinase (ERK) and nuclear factor (NF)-κB p65 phosphorylation in IL-17A-stimulated HPDLCs. Our findings suggested that IL-35 produced from regulatory T cells might inhibit progression of periodontitis by decreasing IL-17A-induced levels of IL-6 and IL-8.
KEY WORDSIL-35 IL-17A IL-6 IL-8 human periodontal ligament cells
This study was supported by Grants-in-Aid for Young Scientists (Start-up) from the Japan Society for the Promotion of Science KAKENHI (Grant No. JP17H06896).
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
- 3.Kotake, S., N. Udagawa, N. Takahashi, K. Matsuzaki, K. Itoh, S. Ishiyama, S. Saito, K. Inoue, N. Kamatani, M.T. Gillespie, T.J. Martin, and T. Suda. 1999. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. Journal of Clinical Investigation 103: 1345–1352.CrossRefPubMedPubMedCentralGoogle Scholar
- 11.Shen, P., T. Roch, V. Lampropoulou, R.A. O'Connor, U. Stervbo, E. Hilgenberg, S. Ries, V.D. Dang, Y. Jaimes, C. Daridon, R. Li, L. Jouneau, P. Boudinot, S. Wilantri, I. Sakwa, Y. Miyazaki, M.D. Leech, R.C. McPherson, S. Wirtz, M. Neurath, K. Hoehlig, E. Meinl, A. Grützkau, J.R. Grün, K. Horn, A.A. Kühl, T. Dörner, A. Bar-Or, S.H.E. Kaufmann, S.M. Anderton, and S. Fillatreau. 2014. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature 507: 366–370.CrossRefPubMedPubMedCentralGoogle Scholar
- 16.Mitani, A., W. Niedbala, T. Fujimura, M. Mogi, S. Miyamae, N. Higuchi, A. Abe, T. Hishikawa, M. Mizutani, Y. Ishihara, H. Nakamura, K. Kurita, N. Ohno, Y. Tanaka, M. Hattori, and T. Noguchi. 2015. Increased expression of interleukin (IL)-35 and IL-17, but not IL-27, in gingival tissues with chronic periodontitis. Journal of Periodontology 86: 301–309.CrossRefPubMedGoogle Scholar
- 19.Köseoğlu, S., M. Sağlam, T. Pekbağrıyanık, L. Savran, and R. Sütçü. 2015. Level of interleukin-35 in gingival crevicular fluid, saliva, and plasma in periodontal disease and health. Journal of Periodontology 24: 1–6.Google Scholar
- 20.Wilson, N.J., K. Boniface, J.R. Chan, B.S. McKenzie, W.M. Blumenschein, J.D. Mattson, B. Basham, K. Smith, T. Chen, F. Morel, J.C. Lecron, R.A. Kastelein, D.J. Cua, T.K. McClanahan, E.P. Bowman, and Malefyt R. de Waal. 2007. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nature Immunology 8: 950–957.CrossRefPubMedGoogle Scholar
- 24.Wang, Y., Y. Mao, J. Zhang, G. Shi, L. Cheng, Y. Lin, Y. Li, X. Zhang, Y. Zhang, X. Chen, J. Deng, X. Su, L. Dai, Y. Yang, S. Zhang, D. Yu, Y. Wei, and H. Deng. 2018. IL-35 recombinant protein reverses inflammatory bowel disease and psoriasis through regulation of inflammatory cytokines and immune cells. Journal of Cellular and Molecular Medicine 22: 1014–1025.PubMedGoogle Scholar
- 25.Zhang, X.H., Y. Zhou, J.M. Zhang, S.Y. Zhou, M. Wang, R. Feng, F.E. Feng, Q.M. Wang, X.L. Zhu, X.S. Zhao, M. Lv, Y. Kong, Y.J. Chang, and X.J. Huang. 2015. IL-35 inhibits acute graft-versus-host disease in a mouse model. International Immunopharmacology 29: 383–392.Google Scholar